Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Convertible Debt (2023 - 2025)

Fractyl Health (GUTS) has disclosed Convertible Debt for 3 consecutive years, with $20.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Convertible Debt changed 0.0% year-over-year to $20.9 million, compared with a TTM value of $20.9 million through Sep 2025, changed 0.0%, and an annual FY2024 reading of $20.9 million, down 23.06% over the prior year.
  • Convertible Debt was $20.9 million for Q3 2025 at Fractyl Health, roughly flat from $20.9 million in the prior quarter.
  • Across five years, Convertible Debt topped out at $27.2 million in Q4 2023 and bottomed at $20.9 million in Q1 2024.
  • Average Convertible Debt over 3 years is $21.7 million, with a median of $20.9 million recorded in 2024.
  • The sharpest move saw Convertible Debt dropped 23.06% in 2024, then increased 0.0% in 2025.
  • Year by year, Convertible Debt stood at $27.2 million in 2023, then decreased by 23.06% to $20.9 million in 2024, then grew by 0.0% to $20.9 million in 2025.
  • Business Quant data shows Convertible Debt for GUTS at $20.9 million in Q3 2025, $20.9 million in Q2 2025, and $20.9 million in Q1 2025.